Wilmslow, United Kingdom

Nigel Philip Taylor

This inventor holds 1 USPTO granted patent. Top assignee: Zeneca Limited. Active years: 1999.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Nigel Philip Taylor. Retrieved from https://idiyas.com/inventor/nigel-philip-taylor-3zt92qvc

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 1999

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Nigel Philip Taylor

Introduction

Nigel Philip Taylor is a notable inventor based in Wilmslow, GB. He has made significant contributions to the field of antifungal treatments, showcasing his expertise through his innovative patent.

Latest Patents

One of his key patents is titled "Process for preparing an antifungal azole with hydrazino and amidrazone." This invention highlights his commitment to advancing medical science and improving treatment options for fungal infections. He holds 1 patent in this area.

Career Highlights

Nigel is currently employed at Zeneca Limited, a company known for its research and development in pharmaceuticals. His work at Zeneca has allowed him to focus on creating effective solutions in the healthcare sector.

Collaborations

Throughout his career, Nigel has collaborated with esteemed colleagues such as Elwyn Peter Davies and John David Pittam. These partnerships have contributed to the success of his projects and innovations.

Conclusion

Nigel Philip Taylor's contributions to the field of antifungal treatments through his patent and work at Zeneca Limited demonstrate his dedication to innovation in healthcare. His efforts continue to impact the industry positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…